Company intelligence
Flip Therapeutics
In vivo Cellular Reprogramming to Rebalance Local Immunity
Biotechnology Research
4 employees
Founded 2024
2 public signals
About Flip Therapeutics
At Flip, we believe that patients with devastating inflammatory and autoimmune diseases need a new paradigm ... curative therapies. Using in vivo cellular reprogramming, we locally rebalance the immune system to produce durable and potentially curative therapies for T cell driven immune disorders.
Verified activity
Signals from Flip Therapeutics
2 published signals
Capital & Finance
Flip Therapeutics secured its initial pre-seed financing, anchored by a £500k investment from the Medicines Discovery Catapult (MDC).
Reported by Flip Therapeutics
Capital & Finance
Flip Therapeutics secured its initial pre-seed financing, anchored by a £500k investment from the Medicines Discovery Catapult (MDC).
Reported by Flip Therapeutics